Appointment will propel STALICLA’s mission to develop their late-stage clinical assets for precision brain disease treatment.

STALICLA Appoints Dr. Thomas Blaettler, MD Date: Friday, Jan. 19, 2024 GENEVA–(BUSINESS WIRE)– STALICLA SA, a Swiss clinical-stage biotechnology company focused on advancing precision medicine for brain diseases, announced today the appointment of Thomas Blaettler, to the position of Chief Medical Officer. Dr. Thomas Blaettler brings a wealth of pharmaceutical development experience and deep insights … Read more

Stalicla’s series B adds $17.4M for trials in substance abuse disorders, ASD

Stalicla SA Secures $17.4 Million in Series B Funding to Advance Innovative Therapies Subtitle: Funding Enables Progress in Treating Cocaine Misuse Disorder and Autism Spectrum Disorder Date: Friday, Jan. 19, 2024 Source: BioWorld (©2024 BioWorld. Reprinted with permission from Clarivate.) Stalicla SA Achieves First Close of $17.4 Million Series B Round for Therapeutic Development BioWorld, … Read more

Building on Existing Technologies

Building on Existing Technologies for a Commercial Prototype Within a Decade Transmutex is pioneering an entirely new type of nuclear energy that promises scalable carbon-free energy without the traditional challenges of existing nuclear plants. Today’s issues with nuclear energy are safety, long-lived waste, and proliferation. Transmutex will allow significant improvements on all these matters, while … Read more

STALICLA secures $17.4 Million in Series B Round

STALICLA’s Precision Neuro Advancements propelled by $17.4 Million in Series B Funding Geneva, Switzerland, January 16th, 2024 – STALICLA SA, a clinical-stage biopharmaceutical company advancing precision medicine pipelines for neuropsychiatric and neurological disorders, announces the successful completion of the first closing of its Series B financing round, securing $17.4 million. Led by SPRIM Global Investments Pte, … Read more

With Proximie to Extend Surgical Excellence Globally

January 10, 2024 Distalmotion – a pioneer in surgical robotics, is partnering with Proximie, the leading global health technology platform digitizing operating rooms (ORs), to extend its ground-breaking Dexter® robotic surgery platform globally. The collaboration provides Distalmotion customers with access to Proximie’s healthcare platform, delivering telepresence, content management, and data driven insights. With Proximie, surgeon … Read more

Revolutionizing Satellite Security

NASA’s Groundbreaking Project To Integrate AI, Blockchain, & Nanosatellites As part of pioneering the security of satellite communication in space, NASA is funding a groundbreaking project at the University of Miami’s Frost Institute for Data Science and Computing (IDSC) which will enable augmenting traditional large satellites with nanosatellites or constellations of nanosatellites. These nanosatellites are … Read more


FenX AG Turgi, Switzerland FenX is a spin-off from ETH Zurich. We tackle the world’s energy and greenhouse gas challenge by bringing technology and innovation to the building insulation market. Our first impact product is a high-performance building insulation panel incorporating mineral waste materials. It is cost effective, fully recyclable and has a low CO2 … Read more

HAYA Therapeutics wins the top prize at the TOP 100 Swiss Startup Award 2023

HAYA rises to the top: The Vaud-based startup ranks first at the TOP 100 Swiss Startup Award 2023. The biotech company leverages the power of the dark genome to develop precise and potent RNA therapies for reprogramming disease-driving cell states. HAYA was founded in 2019 by Samir Ounzain (CEO) and Daniel Blessing (CTO) and ranked … Read more

Follow us on

contact us